Selectis Health, Inc. (GBCS)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Selectis Health, Inc. (GBCS) with AI Score 49/100 (Weak). Selectis Health, Inc. , formerly Global Healthcare REIT, Inc. , is transitioning from a healthcare REIT to owning and operating healthcare properties directly. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 18, 2026Selectis Health, Inc. (GBCS) Healthcare & Pipeline Overview
Selectis Health, Inc. (GBCS) is a healthcare company focused on acquiring, developing, and managing healthcare real estate, shifting from a REIT model to direct ownership and operation of facilities. The company owns twelve healthcare properties, providing both leasing and direct management services within the medical care facilities sector.
Investment Thesis
Selectis Health, Inc. presents a speculative investment opportunity given its transition from a REIT to an owner-operator model in the healthcare real estate sector. The company's strategic shift introduces both potential for increased profitability through direct management and operational control, but also carries significant execution risk. With a market capitalization of $0.01 billion and a negative P/E ratio of -15.73, the company's financial performance requires close monitoring. Key catalysts include successful operational improvements in its directly-managed facilities and strategic deployment of capital. The company's negative beta of -1.05 suggests an inverse correlation to market movements, which could offer diversification benefits. However, the absence of a dividend yield may deter income-focused investors.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.01 billion indicates a micro-cap company with potential for high growth but also significant risk.
- Negative P/E ratio of -15.73 reflects current unprofitability, requiring further investigation into the drivers and potential for turnaround.
- Gross margin of 20.9% indicates the percentage of revenue available to cover operating expenses.
- Profit margin of -1.9% shows the company is currently operating at a loss.
- Beta of -1.05 suggests the stock price moves inversely to the market.
Competitors & Peers
Strengths
- Tangible asset base in healthcare real estate.
- Shift towards direct operation offers potential for higher profitability.
- Expertise in healthcare real estate market.
- Provides financing solutions to healthcare providers.
Weaknesses
- Small market capitalization increases volatility.
- Negative P/E ratio indicates current unprofitability.
- Transition to direct operation introduces execution risk.
- Limited diversification in healthcare properties.
Catalysts
- Upcoming: Potential name change and charter revisions to better reflect the company's current business model.
- Ongoing: Successful transition from a REIT to a direct owner-operator model.
- Ongoing: Strategic acquisitions of additional healthcare properties.
- Ongoing: Value-add investments to improve existing facilities.
Risks
- Potential: Changes in healthcare regulations and reimbursement rates.
- Ongoing: Increased competition from other healthcare REITs and operators.
- Potential: Economic downturn impacting occupancy rates and property values.
- Potential: Rising interest rates increasing borrowing costs.
- Ongoing: Limited financial disclosure increases information asymmetry.
Growth Opportunities
- Direct Operation of Healthcare Facilities: Selectis Health's transition to directly operating its healthcare facilities presents a significant growth opportunity. By assuming direct control, the company can potentially improve operational efficiency, enhance service quality, and capture a larger share of the revenue generated by these facilities. The market for healthcare facility operations is substantial, driven by the increasing demand for senior care and specialized medical services. Successful execution of this strategy could lead to improved profitability and increased asset value.
- Strategic Acquisitions: Selectis Health can pursue strategic acquisitions of additional healthcare properties to expand its portfolio and geographic reach. The healthcare real estate market is fragmented, offering opportunities to acquire undervalued assets or properties with high growth potential. By carefully selecting and integrating new properties, Selectis Health can increase its revenue base, diversify its asset mix, and achieve economies of scale. This growth strategy requires careful due diligence and financial planning to ensure acquisitions are accretive to earnings.
- Value-Add Investments: Selectis Health can invest in upgrading and improving its existing healthcare facilities to enhance their appeal to patients and healthcare providers. This includes modernizing infrastructure, adding new amenities, and implementing technology solutions to improve patient care and operational efficiency. These value-add investments can increase occupancy rates, drive revenue growth, and enhance the overall value of the company's real estate portfolio. The market for healthcare facility improvements is driven by the need to meet evolving patient expectations and regulatory requirements.
- Expansion of Service Offerings: Selectis Health can expand its service offerings within its healthcare facilities to cater to a wider range of patient needs. This could include adding specialized medical services, rehabilitation programs, or assisted living options. By diversifying its service offerings, Selectis Health can attract more patients, increase revenue per patient, and enhance the overall value proposition of its facilities. This growth strategy requires careful market research and investment in skilled healthcare professionals.
- Healthcare Financing Solutions: Selectis Health can leverage its expertise in healthcare real estate to provide financing solutions to healthcare providers. This could include offering bridge loans, construction financing, or sale-leaseback transactions. By providing financing solutions, Selectis Health can generate additional revenue, build relationships with healthcare providers, and gain access to new investment opportunities. The market for healthcare financing is substantial, driven by the capital needs of healthcare providers to expand their operations and invest in new technologies.
Opportunities
- Strategic acquisitions to expand portfolio and geographic reach.
- Value-add investments to improve existing facilities.
- Expansion of service offerings within healthcare facilities.
- Leverage expertise to provide more healthcare financing solutions.
Threats
- Changes in healthcare regulations and reimbursement rates.
- Increased competition from other healthcare REITs and operators.
- Economic downturn impacting occupancy rates and property values.
- Rising interest rates increasing borrowing costs.
Competitive Advantages
- Real estate portfolio provides a tangible asset base.
- Direct operational control offers potential for higher margins.
- Expertise in healthcare real estate provides a competitive advantage.
- Financing solutions create relationships with healthcare providers.
About GBCS
Selectis Health, Inc., formerly known as Global Healthcare REIT, Inc., has evolved from its initial intent of operating as a real estate investment trust (REIT) focused on the healthcare sector. The company's strategy has shifted towards direct ownership and operation of healthcare real estate assets, moving away from the traditional REIT model of leasing properties to independent operators. As a result of this strategic shift, Selectis Health is reevaluating its corporate structure and considering a name change to better reflect its current business model. Originally, the company was named Global Casinos, Inc., which operated two gaming casinos. These casinos were divested on September 30, 2013. Simultaneously, the company acquired West Paces Ferry Healthcare REIT, Inc. (WPF) in a reverse acquisition, with WPF being the accounting acquirer. Selectis Health acquires, develops, leases, manages, and disposes of healthcare real estate. It also provides financing to healthcare providers. As of September 30, 2020, the company owned twelve healthcare properties. These properties are either leased or managed by third-party operators under triple-net operating terms or operated directly by the company. The company strategically operates facilities internally when it is advantageous and expedient to do so.
What They Do
- Acquires healthcare real estate properties.
- Develops healthcare facilities.
- Leases healthcare properties to third-party operators.
- Manages healthcare properties directly.
- Disposes of healthcare real estate assets.
- Provides financing to healthcare providers.
Business Model
- Generates revenue from leasing healthcare properties to third-party operators under triple-net operating terms.
- Generates revenue from operating healthcare facilities directly.
- Generates revenue from providing financing to healthcare providers.
- Generates revenue from the disposition of healthcare real estate assets.
Industry Context
Selectis Health, Inc. operates within the medical care facilities industry, a segment of the broader healthcare sector. This industry is influenced by factors such as aging demographics, healthcare regulations, and reimbursement rates. The competitive landscape includes REITs and healthcare operators. Selectis Health's shift towards direct operation differentiates it from traditional healthcare REITs, potentially offering higher returns but also increased operational complexity. The industry is experiencing growth due to increasing demand for healthcare services, but faces challenges related to cost containment and regulatory compliance.
Key Customers
- Third-party healthcare operators who lease properties from Selectis Health.
- Patients who receive care at Selectis Health's directly-operated facilities.
- Healthcare providers who receive financing from Selectis Health.
Financials
Chart & Info
Selectis Health, Inc. (GBCS) stock price: Price data unavailable
Latest News
No recent news available for GBCS.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GBCS.
Price Targets
Wall Street price target analysis for GBCS.
MoonshotScore
What does this score mean?
The MoonshotScore rates GBCS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Adam Desmond
CEO
Adam Desmond currently serves as the CEO of Selectis Health, Inc. His responsibilities include overseeing the company's strategic direction, operational performance, and financial management. Prior to his role at Selectis Health, details regarding his specific career history, education, and previous roles are not available. However, as CEO, he is responsible for guiding the company through its transition from a REIT to a direct owner-operator model.
Track Record: As CEO, Adam Desmond is currently leading Selectis Health through a strategic shift from a healthcare REIT to direct ownership and operation of healthcare facilities. Specific achievements and milestones under his leadership are not available, but his focus is on improving operational efficiency, enhancing service quality, and driving revenue growth. He is also responsible for managing the company's real estate portfolio and providing financing solutions to healthcare providers.
GBCS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Selectis Health, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited information available to investors, and trading activity may be thin and sporadic. Investing in OTC Other stocks carries significant risks due to the lack of regulatory oversight and potential for fraud or manipulation. These stocks are generally considered highly speculative and suitable only for investors with a high risk tolerance.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Low trading volume and liquidity can lead to price volatility.
- Potential for fraud or manipulation due to lack of regulatory oversight.
- Higher risk of delisting or going out of business.
- Limited analyst coverage and investor awareness.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's capital structure and debt levels.
- Review the company's OTC Markets profile and disclosure statements.
- Check for any regulatory actions or legal proceedings against the company.
- Consult with a qualified financial advisor before investing.
- Company has been in operation for several years.
- Owns tangible assets in the form of healthcare real estate.
- Provides financing solutions to healthcare providers.
- Shift towards direct operation of healthcare facilities suggests a strategic focus.
What Investors Ask About Selectis Health, Inc. (GBCS)
What does Selectis Health, Inc. do?
Selectis Health, Inc. is a healthcare company focused on acquiring, developing, leasing, and managing healthcare real estate. The company is transitioning from a real estate investment trust (REIT) model to directly owning and operating healthcare facilities. As of September 30, 2020, Selectis Health owned twelve healthcare properties, which are either leased or managed by third-party operators or operated directly by the company. The company also provides financing to healthcare providers.
What do analysts say about GBCS stock?
AI analysis is currently pending for GBCS. Due to the lack of analyst coverage and limited information available for OTC-listed companies, a consensus view on GBCS stock is unavailable. Investors should conduct their own due diligence and consider the risks associated with investing in OTC stocks, including limited liquidity and potential for volatility. Key valuation metrics, such as price-to-earnings ratio and price-to-book ratio, should be evaluated in the context of the company's financial performance and growth prospects.
What are the main risks for GBCS?
The main risks for GBCS include its small market capitalization, negative P/E ratio, and the execution risk associated with its transition to a direct owner-operator model. As an OTC-listed company, GBCS faces additional risks related to limited financial disclosure, low trading volume, and potential for fraud or manipulation. Changes in healthcare regulations and reimbursement rates, increased competition, and economic downturns could also negatively impact the company's performance. Investors should carefully consider these risks before investing in GBCS.
What are the key factors to evaluate for GBCS?
Selectis Health, Inc. (GBCS) currently holds an AI score of 49/100, indicating low score. Key strength: Tangible asset base in healthcare real estate.. Primary risk to monitor: Potential: Changes in healthcare regulations and reimbursement rates.. This is not financial advice.
How frequently does GBCS data refresh on this page?
GBCS prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven GBCS's recent stock price performance?
Recent price movement in Selectis Health, Inc. (GBCS) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Tangible asset base in healthcare real estate.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider GBCS overvalued or undervalued right now?
Determining whether Selectis Health, Inc. (GBCS) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying GBCS?
Before investing in Selectis Health, Inc. (GBCS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available sources as of 2026-03-18.
- OTC market data may be limited and less reliable than data for exchange-listed companies.
- AI analysis is pending and may provide additional insights in the future.